Beliefs, behaviors and HPV vaccine

Correcting the myths and the misinformation

Gregory Zimet, Zeev Rosberger, William A. Fisher, Samara Perez, Nathan Stupiansky

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

Objective: Human papillomavirus (HPV) vaccine uptake in many countries has been sub-optimal. We examine several issues associated with non-vaccination that have received particular attention, including fears about sexual risk compensation, concerns about vaccine safety, inadequate vaccination recommendations by health care providers (HCPs), and distrust due to the perceived "newness" of HPV vaccines. Methods: Selective review of behavioral and social science literature on HPV vaccine attitudes and uptake. Results: There is no evidence of post-vaccination sexual risk compensation, HPV vaccines are quite safe, and they can no longer be considered "new". Nonetheless, research findings point to these issues and, most importantly, to the failure of HCPs to adequately recommend HPV vaccine as major drivers of non-vaccination. Conclusion: Most fears related to HPV vaccine are more related to myth than reality. In the absence of major health policy initiatives, such as those implemented in Canada, the U.K., and Australia, a multi-level, multi-faceted approach will be required to achieve high rates of HPV vaccination. It will be essential to focus on the education of HCPs regarding indications for HPV vaccination and approaches to communicating most effectively with parents and patients about the safety and benefits of vaccination and the risks associated with non-vaccination.

Original languageEnglish
Pages (from-to)414-418
Number of pages5
JournalPreventive Medicine
Volume57
Issue number5
DOIs
StatePublished - Nov 2013

Fingerprint

Papillomavirus Vaccines
Communication
Vaccination
Health Personnel
Fear
Behavioral Sciences
Social Sciences
Patient Safety
Health Policy
Canada
Vaccines
Parents
Safety
Education
Research

Keywords

  • Attitude to health
  • Health communication
  • Human papillomavirus vaccines
  • Sexual behavior

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Epidemiology

Cite this

Beliefs, behaviors and HPV vaccine : Correcting the myths and the misinformation. / Zimet, Gregory; Rosberger, Zeev; Fisher, William A.; Perez, Samara; Stupiansky, Nathan.

In: Preventive Medicine, Vol. 57, No. 5, 11.2013, p. 414-418.

Research output: Contribution to journalArticle

Zimet, Gregory ; Rosberger, Zeev ; Fisher, William A. ; Perez, Samara ; Stupiansky, Nathan. / Beliefs, behaviors and HPV vaccine : Correcting the myths and the misinformation. In: Preventive Medicine. 2013 ; Vol. 57, No. 5. pp. 414-418.
@article{52d1aa026a5145eb83d4b5f9b5186c76,
title = "Beliefs, behaviors and HPV vaccine: Correcting the myths and the misinformation",
abstract = "Objective: Human papillomavirus (HPV) vaccine uptake in many countries has been sub-optimal. We examine several issues associated with non-vaccination that have received particular attention, including fears about sexual risk compensation, concerns about vaccine safety, inadequate vaccination recommendations by health care providers (HCPs), and distrust due to the perceived {"}newness{"} of HPV vaccines. Methods: Selective review of behavioral and social science literature on HPV vaccine attitudes and uptake. Results: There is no evidence of post-vaccination sexual risk compensation, HPV vaccines are quite safe, and they can no longer be considered {"}new{"}. Nonetheless, research findings point to these issues and, most importantly, to the failure of HCPs to adequately recommend HPV vaccine as major drivers of non-vaccination. Conclusion: Most fears related to HPV vaccine are more related to myth than reality. In the absence of major health policy initiatives, such as those implemented in Canada, the U.K., and Australia, a multi-level, multi-faceted approach will be required to achieve high rates of HPV vaccination. It will be essential to focus on the education of HCPs regarding indications for HPV vaccination and approaches to communicating most effectively with parents and patients about the safety and benefits of vaccination and the risks associated with non-vaccination.",
keywords = "Attitude to health, Health communication, Human papillomavirus vaccines, Sexual behavior",
author = "Gregory Zimet and Zeev Rosberger and Fisher, {William A.} and Samara Perez and Nathan Stupiansky",
year = "2013",
month = "11",
doi = "10.1016/j.ypmed.2013.05.013",
language = "English",
volume = "57",
pages = "414--418",
journal = "Preventive Medicine",
issn = "0091-7435",
publisher = "Academic Press Inc.",
number = "5",

}

TY - JOUR

T1 - Beliefs, behaviors and HPV vaccine

T2 - Correcting the myths and the misinformation

AU - Zimet, Gregory

AU - Rosberger, Zeev

AU - Fisher, William A.

AU - Perez, Samara

AU - Stupiansky, Nathan

PY - 2013/11

Y1 - 2013/11

N2 - Objective: Human papillomavirus (HPV) vaccine uptake in many countries has been sub-optimal. We examine several issues associated with non-vaccination that have received particular attention, including fears about sexual risk compensation, concerns about vaccine safety, inadequate vaccination recommendations by health care providers (HCPs), and distrust due to the perceived "newness" of HPV vaccines. Methods: Selective review of behavioral and social science literature on HPV vaccine attitudes and uptake. Results: There is no evidence of post-vaccination sexual risk compensation, HPV vaccines are quite safe, and they can no longer be considered "new". Nonetheless, research findings point to these issues and, most importantly, to the failure of HCPs to adequately recommend HPV vaccine as major drivers of non-vaccination. Conclusion: Most fears related to HPV vaccine are more related to myth than reality. In the absence of major health policy initiatives, such as those implemented in Canada, the U.K., and Australia, a multi-level, multi-faceted approach will be required to achieve high rates of HPV vaccination. It will be essential to focus on the education of HCPs regarding indications for HPV vaccination and approaches to communicating most effectively with parents and patients about the safety and benefits of vaccination and the risks associated with non-vaccination.

AB - Objective: Human papillomavirus (HPV) vaccine uptake in many countries has been sub-optimal. We examine several issues associated with non-vaccination that have received particular attention, including fears about sexual risk compensation, concerns about vaccine safety, inadequate vaccination recommendations by health care providers (HCPs), and distrust due to the perceived "newness" of HPV vaccines. Methods: Selective review of behavioral and social science literature on HPV vaccine attitudes and uptake. Results: There is no evidence of post-vaccination sexual risk compensation, HPV vaccines are quite safe, and they can no longer be considered "new". Nonetheless, research findings point to these issues and, most importantly, to the failure of HCPs to adequately recommend HPV vaccine as major drivers of non-vaccination. Conclusion: Most fears related to HPV vaccine are more related to myth than reality. In the absence of major health policy initiatives, such as those implemented in Canada, the U.K., and Australia, a multi-level, multi-faceted approach will be required to achieve high rates of HPV vaccination. It will be essential to focus on the education of HCPs regarding indications for HPV vaccination and approaches to communicating most effectively with parents and patients about the safety and benefits of vaccination and the risks associated with non-vaccination.

KW - Attitude to health

KW - Health communication

KW - Human papillomavirus vaccines

KW - Sexual behavior

UR - http://www.scopus.com/inward/record.url?scp=84885864927&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885864927&partnerID=8YFLogxK

U2 - 10.1016/j.ypmed.2013.05.013

DO - 10.1016/j.ypmed.2013.05.013

M3 - Article

VL - 57

SP - 414

EP - 418

JO - Preventive Medicine

JF - Preventive Medicine

SN - 0091-7435

IS - 5

ER -